PE20000115A1 - Forma termodinamicamente estable del acido (r)-3-[[(4-fluorofenil)sulfonil]amino]-1,2,3,4-tetrahidro-9h-carbazol-9-propanoico (ramatroban) - Google Patents

Forma termodinamicamente estable del acido (r)-3-[[(4-fluorofenil)sulfonil]amino]-1,2,3,4-tetrahidro-9h-carbazol-9-propanoico (ramatroban)

Info

Publication number
PE20000115A1
PE20000115A1 PE1998001272A PE00127298A PE20000115A1 PE 20000115 A1 PE20000115 A1 PE 20000115A1 PE 1998001272 A PE1998001272 A PE 1998001272A PE 00127298 A PE00127298 A PE 00127298A PE 20000115 A1 PE20000115 A1 PE 20000115A1
Authority
PE
Peru
Prior art keywords
ramatroban
spectrum
conversion
thermodynamically stable
sulfonil
Prior art date
Application number
PE1998001272A
Other languages
English (en)
Spanish (es)
Inventor
Alfons Grunenberg
Karl-Hainz Wahl
Klaus-Peter Voges
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of PE20000115A1 publication Critical patent/PE20000115A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
PE1998001272A 1997-12-24 1998-12-22 Forma termodinamicamente estable del acido (r)-3-[[(4-fluorofenil)sulfonil]amino]-1,2,3,4-tetrahidro-9h-carbazol-9-propanoico (ramatroban) PE20000115A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)

Publications (1)

Publication Number Publication Date
PE20000115A1 true PE20000115A1 (es) 2000-03-26

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001272A PE20000115A1 (es) 1997-12-24 1998-12-22 Forma termodinamicamente estable del acido (r)-3-[[(4-fluorofenil)sulfonil]amino]-1,2,3,4-tetrahidro-9h-carbazol-9-propanoico (ramatroban)

Country Status (36)

Country Link
US (1) US6362214B1 (enExample)
EP (1) EP1051398B1 (enExample)
JP (2) JP3817668B2 (enExample)
KR (1) KR100586350B1 (enExample)
CN (1) CN1140510C (enExample)
AR (1) AR013803A1 (enExample)
AT (1) ATE263152T1 (enExample)
AU (1) AU744242B2 (enExample)
BG (1) BG65024B1 (enExample)
BR (1) BR9814496A (enExample)
CA (1) CA2313230A1 (enExample)
CO (1) CO4970800A1 (enExample)
DE (2) DE19757983A1 (enExample)
DK (1) DK1051398T3 (enExample)
ES (1) ES2218874T3 (enExample)
GT (1) GT199800198A (enExample)
HN (1) HN1998000186A (enExample)
HU (1) HUP0004432A3 (enExample)
ID (1) ID25446A (enExample)
IL (1) IL136278A (enExample)
IN (1) IN192932B (enExample)
MY (1) MY116312A (enExample)
NO (1) NO316618B1 (enExample)
NZ (1) NZ504741A (enExample)
PE (1) PE20000115A1 (enExample)
PL (1) PL341359A1 (enExample)
PT (1) PT1051398E (enExample)
RU (1) RU2220137C2 (enExample)
SI (1) SI1051398T1 (enExample)
SK (1) SK285109B6 (enExample)
TR (1) TR200001936T2 (enExample)
TW (1) TW552258B (enExample)
UA (1) UA66832C2 (enExample)
UY (2) UY25324A1 (enExample)
WO (1) WO1999033803A1 (enExample)
ZA (1) ZA9811817B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100168137A1 (en) * 2006-12-20 2010-07-01 Johan Raud Combination for use in the treatment of inflammatory disorders
WO2008087371A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
JP6770522B2 (ja) 2015-02-13 2020-10-14 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 全身性エリテマトーデスを予防し、及び/又は、治療するためのptgdr−1及び/又はptgdr−2アンタゴニスト

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557665A (en) * 1975-12-10 1979-12-12 Ici Ltd Process for the manufacture of a carboxyalkylamino anthraquinone compounds
US4616028A (en) * 1985-04-22 1986-10-07 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use
CN1015711B (zh) 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1,2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
DE19506739A1 (de) 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
IL136278A (en) 2005-03-20
US6362214B1 (en) 2002-03-26
TW552258B (en) 2003-09-11
TR200001936T2 (tr) 2001-01-22
UY25324A1 (es) 2000-12-29
IL136278A0 (en) 2001-05-20
MY116312A (en) 2003-12-31
JP2006151977A (ja) 2006-06-15
EP1051398B1 (en) 2004-03-31
CN1282320A (zh) 2001-01-31
IN192932B (enExample) 2004-06-12
NZ504741A (en) 2002-10-25
SK9752000A3 (en) 2001-02-12
NO316618B1 (no) 2004-03-08
UY25575A1 (es) 1999-11-17
EP1051398A1 (en) 2000-11-15
AU744242B2 (en) 2002-02-21
HN1998000186A (es) 1999-11-03
SI1051398T1 (en) 2004-08-31
UA66832C2 (uk) 2004-06-15
KR20010033529A (ko) 2001-04-25
BG104554A (en) 2001-05-31
DE19757983A1 (de) 1999-07-01
PL341359A1 (en) 2001-04-09
NO20003217L (no) 2000-06-21
WO1999033803A1 (en) 1999-07-08
CO4970800A1 (es) 2000-11-07
DK1051398T3 (da) 2004-07-19
PT1051398E (pt) 2004-07-30
HUP0004432A3 (en) 2002-10-28
BR9814496A (pt) 2000-10-10
GT199800198A (es) 1998-12-15
KR100586350B1 (ko) 2006-06-07
SK285109B6 (sk) 2006-06-01
NO20003217D0 (no) 2000-06-21
ATE263152T1 (de) 2004-04-15
JP3817668B2 (ja) 2006-09-06
HUP0004432A2 (hu) 2001-06-28
DE69822882D1 (en) 2004-05-06
JP2001527067A (ja) 2001-12-25
AU1687499A (en) 1999-07-19
JP4411269B2 (ja) 2010-02-10
CN1140510C (zh) 2004-03-03
HK1034517A1 (en) 2001-10-26
BG65024B1 (bg) 2006-12-29
DE69822882T2 (de) 2005-02-03
ES2218874T3 (es) 2004-11-16
CA2313230A1 (en) 1999-07-08
ID25446A (id) 2000-10-05
ZA9811817B (en) 1999-06-29
AR013803A1 (es) 2001-01-10
RU2220137C2 (ru) 2003-12-27

Similar Documents

Publication Publication Date Title
CO5390079A1 (es) Compuestos heterociclicos novedosos que tienen actividades hipolipidemicas, hipocolesterolicas, proceso para su preparacion y composiciones farmaceuticas que los contienen y su uso en medicina
ZA908884B (en) 1,2-benzisoxazole derivatives processes for preparing them and pharmaceutical compositions containing them
PE20030629A1 (es) Sal sodica cristalina y procedimiento para su preparacion
AR029570A1 (es) Nueva forma cristalina gamma de la sal de terbutilamina de perindopril, procedimiento para su preparacion y composiciones farmaceuticas que la contienen
DK422583A (da) Fremgangsmaade til fremstilling af diazobicyclo-(3,3,1)-nonaner
BR1100379A (pt) Composto, uso de um composto, preparação farmacêutica e processo para preparação de um composto
Hoyer et al. The structure of xenon hexafluoride in the solid state
SE8701406L (sv) Aromatiska foreningar, deras framtellningsforfarande och deras anvendning inom human- och veterinermedicinen och inom kosmetiken
ATE38988T1 (de) Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
NZ216048A (en) Quinolylglycinamide derivatives, and pharmaceutical compositions containing such
CO5180567A1 (es) Sal polimor
ES2043070T3 (es) Procedimiento para la preparacion de derivados de la benzotiazolamina-2.
ES2183492T3 (es) Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
JPS5657875A (en) Electrochromic display device
DE50304891D1 (de) N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel
ES2056639T3 (es) Procedimiento para la transformacion del acido (benzoil-3 fenil)-2 propionico-r(-) en isomero s(+).
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
BR8803402A (pt) Poliisocianatos aromaticos,processo para a sua preparacao e utilizacao
Szarek et al. Utility of tris (dimethylamino) sulphonium difluorotrimethylsilicate (TASF) for the rapid synthesis of deoxyfluoro sugars
DK597786D0 (da) Krystallinske salte af aryloxypropanolaminer og fremgangsmaade til fremstilling heraf
AR013803A1 (es) Forma cristalina del acido (r)-3-[[(4-fluorfenil)sulfonil]amino]-1,2,3,4- tetrahidro-9h-carbazol-9-propanoico (ramatroban), proceso para su preparacion,su uso para la manufactura de un medicamento y medicamento que la contiene
ES8602002A1 (es) Procedimiento para preparar nuevas 4-fenil-tetrahidrofurano-(2,3-c)priridinas
ES8401485A1 (es) Un procedimiento de preparacion de nuevas 8-(3-(1,2-bencisoxazol-3-il)propil)-1-fenil-1,3,8-triazaspiro(4,5)decan-4-onas.
ES8105691A1 (es) Procedimiento para separar d-acido 2-(6-metoxi-2-naftil)- propionico de una mezcla de d-y 1-acidos 2-(6-metoxi-2-naf- til)-propionicos o sus sales
ES2138226T3 (es) Derivados del acido imidazo(1,2-a)indeno(1,2-e)pirazina-2-carboxilico, su preparacion y los medicamentos que les contienen.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed